Minimum target prices for production of direct-acting antivirals and associated diagnostics to combat hepatitis C virus

Combinations of direct-acting antivirals (DAAs) can cure hepatitis C virus (HCV) in the majority of treatment-naïve patients. Mass treatment programs to cure HCV in developing countries are only feasible if the costs of treatment and laboratory diagnostics are very low. This analysis aimed to estima...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Ven, Nikolien, Fortunak, Joe, Simmons, Bryony, Ford, Nathan, Cooke, Graham S, Khoo, Saye, Hill, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403972/
https://www.ncbi.nlm.nih.gov/pubmed/25482139
http://dx.doi.org/10.1002/hep.27641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403972/
https://www.ncbi.nlm.nih.gov/pubmed/25482139
http://dx.doi.org/10.1002/hep.27641

Ejemplares similares